ELUNATE Trademark

Trademark Overview


On Friday, November 18, 2011, a trademark application was filed for ELUNATE with the United States Patent and Trademark Office. The USPTO has given the ELUNATE trademark a serial number of 85476701. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 8, 2014. This trademark is owned by Eli Lilly and Company. The ELUNATE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antipsychotic pharmaceutical preparations; ...
elunate

General Information


Serial Number85476701
Word MarkELUNATE
Filing DateFriday, November 18, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 8, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 11, 2012

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antipsychotic pharmaceutical preparations; and antidepressants

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 28, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, December 8, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, December 8, 2014ABANDONMENT - NO USE STATEMENT FILED
Friday, April 4, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 3, 2014EXTENSION 3 GRANTED
Tuesday, March 25, 2014EXTENSION 3 FILED
Tuesday, March 25, 2014TEAS EXTENSION RECEIVED
Tuesday, November 5, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 4, 2013EXTENSION 2 GRANTED
Monday, October 28, 2013EXTENSION 2 FILED
Monday, October 28, 2013TEAS EXTENSION RECEIVED
Wednesday, May 29, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 28, 2013EXTENSION 1 GRANTED
Sunday, May 5, 2013EXTENSION 1 FILED
Friday, May 24, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 1, 2013TEAS EXTENSION RECEIVED
Tuesday, November 6, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 11, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 11, 2012PUBLISHED FOR OPPOSITION
Wednesday, August 22, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, August 6, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Sunday, August 5, 2012ASSIGNED TO LIE
Thursday, July 19, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 3, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 3, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 3, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 6, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 6, 2012NON-FINAL ACTION E-MAILED
Tuesday, March 6, 2012NON-FINAL ACTION WRITTEN
Tuesday, March 6, 2012ASSIGNED TO EXAMINER
Monday, November 28, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, November 22, 2011NEW APPLICATION ENTERED IN TRAM